Incyte Corp
(INCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 5,141,242 | 4,241,217 | 3,695,649 | 3,394,635 | 2,986,267 |
| Cost of Goods | 372,130 | 312,068 | 254,990 | 206,997 | 150,991 |
| Gross Profit | 4,769,112 | 3,929,149 | 3,440,659 | 3,187,638 | 2,835,276 |
| Operating Expenses | 3,254,383 | 3,867,851 | 2,821,124 | 2,609,195 | 2,250,490 |
| Operating Income | 1,514,859 | 61,366 | 620,525 | 579,440 | 585,777 |
| Interest Expense | 2,428 | 2,280 | 2,551 | 2,666 | 1,908 |
| Other Income | 152,020 | 257,544 | 216,241 | -47,658 | -13,425 |
| Pre-tax Income | 1,664,451 | 316,630 | 834,215 | 529,116 | 570,444 |
| Income Tax | 377,801 | 284,015 | 236,616 | 188,456 | -378,137 |
| Net Income Continuous | 1,286,650 | 32,615 | 597,599 | 340,660 | 948,581 |
| Net Income | $1,286,650 | $32,615 | $597,599 | $340,660 | $948,581 |
| EPS Basic Total Ops | 6.59 | 0.16 | 2.67 | 1.53 | 4.30 |
| EPS Basic Continuous Ops | 6.59 | 0.16 | 2.67 | 1.53 | 4.30 |
| EPS Diluted Total Ops | 6.41 | 0.15 | 2.65 | 1.52 | 4.27 |
| EPS Diluted Continuous Ops | 6.41 | 0.15 | 2.65 | 1.52 | 4.27 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.08 | 2.69 | 2.11 | 2.11 |
| EBITDA(a) | $1,608,145 | $150,614 | $703,185 | $647,295 | $643,621 |